Rare
lephants
Screener
Toggle theme
Cellyan Biotechnology Co., Ltd
HKPD
·
Healthcare, Medical Distribution
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2023
Total Cash from Operations:
$2.6M
Line Item
Value
% of Total
Capital Expenditures
$69.9K
2.7%
Other Investing
$2.4M
92.6%
Net Cash Flow
$121.9K
4.7%
Download CSV
